Worthy deduction FF, in principle I agree. A dynamic, fluid, forward thinking company would be doing so much more.
However it would appear to be clutching at straws. We are dealing with a company that moves at a snails pace, and that's on a good day.
Decades have passed, Immuron have two products to market one of which receives mediocre publicity and one that receives literally none. Two compounds IMM-124E, that they are finally seeking FDA approval for, and IMM-529, that has shown significant pre-clinical results re. C.diff, has had its clinical trial cancelled and appears to have now been shelved.
For the board and management to watch the share price tank and not release some form of positive forward looking statement shows the disregard held for the shareholders of this company, bordering on contempt.
I too wish we were dealing with a fluid and dynamic company, however the evidence suggests to believe so, is delusional.
.
IMC Price at posting:
7.8¢ Sentiment: Hold Disclosure: Held
